Evans A

Abstract Endometriosis is a chronic inflammatory condition with significant diagnostic delays impacting one in ten reproductive age women worldwide. While machine learning (ML) models trained on transcriptomic data show promise for disease …

Study questionHow does two-consecutive single embryo transfer (2xSET) affect reproductive outcomes of IVF and ICSI compared to double embryo transfer (DET)?Summary answerTwo-consecutive SET may provide greater or comparable live birth rate …

High-grade serous ovarian cancer (HGSOC) is a heterogeneous disease, but efforts to define transcriptional subtypes using bulk RNA sequencing have been confounded by the presence of non-malignant cells. As a result, it remains unclear wheth…

Pancreatic ductal adenocarcinoma (PDAC) is the deadliest of the common cancers, with a dismal prognosis attributed in part to late diagnosis in the majority of patients. Diagnosing early stage increases the likelihood of eligibility for sur…

Pancreatic ductal adenocarcinoma (PDAC) is the deadliest of the common cancers, with a dismal prognosis attributed in part to late diagnosis in the majority of patients. Diagnosing early stage increases the likelihood of eligibility for sur…

Pancreatic ductal adenocarcinoma (PDAC) is the deadliest of the common cancers, with a dismal prognosis attributed in part to late diagnosis in the majority of patients. Diagnosing early stage increases the likelihood of eligibility for sur…

Pancreatic ductal adenocarcinoma (PDAC) is the deadliest of the common cancers, with a dismal prognosis attributed in part to late diagnosis in the majority of patients. Diagnosing early stage increases the likelihood of eligibility for sur…

Pancreatic ductal adenocarcinoma (PDAC) is the deadliest of the common cancers, with a dismal prognosis attributed in part to late diagnosis in the majority of patients. Diagnosing early stage increases the likelihood of eligibility for sur…

Pancreatic ductal adenocarcinoma (PDAC) is the deadliest of the common cancers, with a dismal prognosis attributed in part to late diagnosis in the majority of patients. Diagnosing early stage increases the likelihood of eligibility for sur…

Pancreatic ductal adenocarcinoma (PDAC) is the deadliest of the common cancers, with a dismal prognosis attributed in part to late diagnosis in the majority of patients. Diagnosing early stage increases the likelihood of eligibility for sur…

Pancreatic ductal adenocarcinoma (PDAC) is the deadliest of the common cancers, with a dismal prognosis attributed in part to late diagnosis in the majority of patients. Diagnosing early stage increases the likelihood of eligibility for sur…

Pancreatic ductal adenocarcinoma (PDAC) is the deadliest of the common cancers, with a dismal prognosis attributed in part to late diagnosis in the majority of patients. Diagnosing early stage increases the likelihood of eligibility for sur…

Pancreatic ductal adenocarcinoma (PDAC) is the deadliest of the common cancers, with a dismal prognosis attributed in part to late diagnosis in the majority of patients. Diagnosing early stage increases the likelihood of eligibility for sur…

Pancreatic ductal adenocarcinoma (PDAC) is the deadliest of the common cancers, with a dismal prognosis attributed in part to late diagnosis in the majority of patients. Diagnosing early stage increases the likelihood of eligibility for sur…

Pancreatic ductal adenocarcinoma (PDAC) is the deadliest of the common cancers, with a dismal prognosis attributed in part to late diagnosis in the majority of patients. Diagnosing early stage increases the likelihood of eligibility for sur…

Pancreatic ductal adenocarcinoma (PDAC) is the deadliest of the common cancers, with a dismal prognosis attributed in part to late diagnosis in the majority of patients. Diagnosing early stage increases the likelihood of eligibility for sur…

Pancreatic ductal adenocarcinoma (PDAC) is the deadliest of the common cancers, with a dismal prognosis attributed in part to late diagnosis in the majority of patients. Diagnosing early stage increases the likelihood of eligibility for sur…

Pancreatic ductal adenocarcinoma (PDAC) is the deadliest of the common cancers, with a dismal prognosis attributed in part to late diagnosis in the majority of patients. Diagnosing early stage increases the likelihood of eligibility for sur…

Pancreatic ductal adenocarcinoma (PDAC) is the deadliest of the common cancers, with a dismal prognosis attributed in part to late diagnosis in the majority of patients. Diagnosing early stage increases the likelihood of eligibility for sur…

Pancreatic ductal adenocarcinoma (PDAC) is the deadliest of the common cancers, with a dismal prognosis attributed in part to late diagnosis in the majority of patients. Diagnosing early stage increases the likelihood of eligibility for sur…

Pancreatic ductal adenocarcinoma (PDAC) is the deadliest of the common cancers, with a dismal prognosis attributed in part to late diagnosis in the majority of patients. Diagnosing early stage increases the likelihood of eligibility for sur…

Pancreatic ductal adenocarcinoma (PDAC) is the deadliest of the common cancers, with a dismal prognosis attributed in part to late diagnosis in the majority of patients. Diagnosing early stage increases the likelihood of eligibility for sur…

Pancreatic ductal adenocarcinoma (PDAC) is the deadliest of the common cancers, with a dismal prognosis attributed in part to late diagnosis in the majority of patients. Diagnosing early stage increases the likelihood of eligibility for sur…

Pancreatic ductal adenocarcinoma (PDAC) is the deadliest of the common cancers, with a dismal prognosis attributed in part to late diagnosis in the majority of patients. Diagnosing early stage increases the likelihood of eligibility for sur…